Improved haemodynamic stability and cerebral tissue oxygenation after induction of anaesthesia with sufentanil compared to remifentanil: a randomised controlled trial

Table 2 Haemodynamic data in the sufentanil and remifentanil group after the induction of anaesthesia

		T₀	T₆	∆	P - value*
MAP (mmHg)	Sufentanil	101 ± 15	78 ± 15	− 23 ± 13	< 0.001
	Remifentanil	100 ± 11	65 ± 11	−36 ± 13	< 0.001
HR (bpm)	Sufentanil	64 ± 9	59 ± 8	−5 ± 7	< 0.001
	Remifentanil	68 ± 14	58 ± 12	− 10 ± 10	0.001
SV (ml)	Sufentanil	101 ± 25	78 ± 21	− 23 ± 18	< 0.001
	Remifentanil	97 ± 21	62 ± 21	− 35 ± 19	< 0.001
CI (l min^− 1 m^− 2)	Sufentanil	3.2 (2.7 to 3.9)	2.3 (1.8 to 2.8)	−0.8 (− 1.5 to − 0.5)	< 0.001
	Remifentanil	3.5 (2.7 to 3.9)	1.8 (1.4 to 2.3)	−1.5 (− 2.0 to − 1.1)	< 0.001
RPP (mmHg bpm)	Sufentanil	10,004 ± 2200	6928 ± 1893	−3077 ± 2010	< 0.001
	Remifentanil	10,730 ± 2444	5728 ± 1845	−5002 ± 2369	< 0.001
SctO₂ (%)	Sufentanil	68 ± 8	77 ± 7	9 ± 5	< 0.001
	Remifentanil	67 ± 7	73 ± 8	6 ± 4	< 0.001
SptO₂ (%)	Sufentanil	77 ± 10	85 ± 7	8 ± 7	< 0.001
	Remifentanil	72 ± 11	80 ± 9	8 ± 8	< 0.001

Variables are reported as mean ± SD or median (IQR), according to data distribution
∆: value (T₆) – value (T₀); MAP Mean Arterial Pressure; HR Heart Rate; SV Stroke Volume; CO Cardiac Output; SctO₂ Cerebral Tissue Oxygen Saturation; SptO₂ Peripheral Tissue Oxygen Saturation
* (T₆ vs. T₀), paired t-test or Wilcoxon signed rank test

ISSN: 1471-2253